Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to HER2-negative Breast Cancer
Related studies linked through entity extraction aliases.
Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
- Status
- COMPLETED
- Phase
- N/A
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab
- Status
- RECRUITING
- Phase
- PHASE2
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
New Digital Person-based Care Model in Patients With HER2-negative Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis
- Status
- RECRUITING
- Phase
- PHASE4
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
- Status
- RECRUITING
- Phase
- PHASE2